131 related articles for article (PubMed ID: 32808506)
1. Letter to editor in response to: Comparison of diagnostic accuracy between endometrial curettage and aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group study.
Sabour S; Shokrgozar M
J Gynecol Oncol; 2020 Sep; 31(5):e88. PubMed ID: 32808506
[No Abstract] [Full Text] [Related]
2. Response to comment on: Comparison of diagnostic accuracy between endometrial curettage and aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group study.
Kim MK; Seong SJ
J Gynecol Oncol; 2020 Sep; 31(5):e89. PubMed ID: 32808507
[No Abstract] [Full Text] [Related]
3. Comparison of diagnostic accuracy between endometrial curettage and aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group study.
Kim MK; Seong SJ; Park DC; Hong JH; Roh JW; Kang SB
J Gynecol Oncol; 2020 Jul; 31(4):e51. PubMed ID: 32266800
[TBL] [Abstract][Full Text] [Related]
4. Comparison of diagnostic accuracy between endometrial curettage and pipelle aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group Study (KGOG 2019).
Kim MK; Seong SJ; Lee TS; Ki KD; Lim MC; Kim YH; Kim K; Joo WD
Jpn J Clin Oncol; 2015 Oct; 45(10):980-2. PubMed ID: 26206899
[TBL] [Abstract][Full Text] [Related]
5. Comparison of dilatation & curettage and endometrial aspiration biopsy accuracy in patients treated with high-dose oral progestin plus levonorgestrel intrauterine system for early-stage endometrial cancer.
Kim MK; Seong SJ; Song T; Kim ML; Yoon BS; Jun HS; Lee GH; Lee YH
Gynecol Oncol; 2013 Sep; 130(3):470-3. PubMed ID: 23822890
[TBL] [Abstract][Full Text] [Related]
6. Dilatation and curettage is more accurate than endometrial aspiration biopsy in early-stage endometrial cancer patients treated with high dose oral progestin and levonorgestrel intrauterine system.
Kim DH; Seong SJ; Kim MK; Bae HS; Kim M; Yun BS; Jung YW; Shim JY
J Gynecol Oncol; 2017 Jan; 28(1):e1. PubMed ID: 27670255
[TBL] [Abstract][Full Text] [Related]
7. Management of Endometrial Hyperplasia With a Levonorgestrel-Releasing Intrauterine System: A Korean Gynecologic-Oncology Group Study.
Kim MK; Seong SJ; Kim JW; Jeon S; Choi HS; Lee IH; Lee JH; Ju W; Song ES; Park H; Ryu HS; Lee C; Kang SB
Int J Gynecol Cancer; 2016 May; 26(4):711-5. PubMed ID: 26905333
[TBL] [Abstract][Full Text] [Related]
8. Management of endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: single arm, prospective multicenter study: Korean gynecologic oncology group study (KGOG2006).
Lee TS; Seong SJ; Kim JW; Ryu HS; Song ES; Nam BH
Jpn J Clin Oncol; 2011 Jun; 41(6):817-9. PubMed ID: 21478178
[TBL] [Abstract][Full Text] [Related]
9. Comparison the Diagnostic Value of Dilatation and Curettage Versus Endometrial Biopsy by Pipelle--a Clinical Trial.
Sanam M; Majid MM
Asian Pac J Cancer Prev; 2015; 16(12):4971-5. PubMed ID: 26163624
[TBL] [Abstract][Full Text] [Related]
10. Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
Wheeler DT; Bristow RE; Kurman RJ
Am J Surg Pathol; 2007 Jul; 31(7):988-98. PubMed ID: 17592264
[TBL] [Abstract][Full Text] [Related]
11. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016
[TBL] [Abstract][Full Text] [Related]
12. Six months response rate of combined oral medroxyprogesterone/levonorgestrel-intrauterine system for early-stage endometrial cancer in young women: a Korean Gynecologic-Oncology Group Study.
Kim MK; Seong SJ; Kang SB; Bae DS; Kim JW; Nam JH; Lim MC; Lee TS; Kim S; Paek J
J Gynecol Oncol; 2019 Mar; 30(2):e47. PubMed ID: 30740964
[TBL] [Abstract][Full Text] [Related]
13. Endometrial squamous metaplasia. An unusual response to progestin therapy of hyperplasia.
Miranda MC; Mazur MT
Arch Pathol Lab Med; 1995 May; 119(5):458-60. PubMed ID: 7748076
[TBL] [Abstract][Full Text] [Related]
14. Does repetitive dilatation and curettage or hysteroscopic biopsy in patients treated with progestins for endometrial hyperplasia or carcinoma affect subsequent fetomaternal outcomes? A population-based study using the National Health Insurance Research Database of Taiwan.
Lin H; Chen WH; Chen CY; Yang YH; Lee CP; Chen KJ; Ou YC
Int J Gynaecol Obstet; 2024 Feb; 164(2):605-612. PubMed ID: 37723982
[TBL] [Abstract][Full Text] [Related]
15. Preoperative and postoperative correlation of histopathological findings in cases of endometrial hyperplasia.
Gundem G; Sendag F; Kazandi M; Akercan F; Mgoyi L; Terek MC; Zekioglu O
Eur J Gynaecol Oncol; 2003; 24(3-4):330-3. PubMed ID: 12807251
[TBL] [Abstract][Full Text] [Related]
16. Endometrial curettage in abnormal uterine bleeding and efficacy of progestins for control in cases of hyperplasia.
Mesci-Haftaci S; Ankarali H; Yavuzcan A; Caglar M
Asian Pac J Cancer Prev; 2014; 15(8):3737-40. PubMed ID: 24870785
[TBL] [Abstract][Full Text] [Related]
17. Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
Witkiewicz AK; McConnell T; Potoczek M; Emmons RV; Kurman RJ
Hum Pathol; 2010 Jan; 41(1):26-32. PubMed ID: 19733383
[TBL] [Abstract][Full Text] [Related]
18. [Pregnant rate and pregnancy-relating factors of patients with early endometrial carcinoma and severe atypical hyperplasia of endometrium after fertility-preserving treatment by progestin].
Cao DY; Yu M; Yang JX; Shen K; Huang HF; Cheng NH; Sun ZY; Deng CY; Yu Q; He FF
Zhonghua Fu Chan Ke Za Zhi; 2013 Jul; 48(7):519-22. PubMed ID: 24284224
[TBL] [Abstract][Full Text] [Related]
19. [Value of endometrial aspiration cytology in assessing endometrial status].
Zhou XS
Zhonghua Fu Chan Ke Za Zhi; 1989 Mar; 24(2):89-90, 124. PubMed ID: 2758913
[TBL] [Abstract][Full Text] [Related]
20. Hormonal inhibition of the endometrium for resectoscopic endometrial ablation.
Brooks PG; Serden SP; Davos I
Am J Obstet Gynecol; 1991 Jun; 164(6 Pt 1):1601-6; discussion 1606-8. PubMed ID: 1904683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
